סרטונים

References

TECVAYLI® patient information leaflet approved by the Israeli MOH
Shimabukuro-Vornhagen A et al. J Immunother Cancer 2018; 6(1):56.
Lee DW et al. Blood 2014; 124(2):188–1953
Rasche L et al. Haematologica 2021; 106(10):2555–2565
TECVAYLI® prescribing information (Pl} approved by the Israeli MOH
Logo Janssen | Pharmaceutical Companies of Johnson & Johnson